Live Placebo updates

Live Placebo news coverage of developments with the latest updates. Stay on top of latest Placebo news stories and find out what just happened, what is going on with Placebo. The latest real-time news updates and headlines on Placebo
Tranexamic Acid Halts Severe Bleeding in C-Sections
Obesity Drug Treatment Preserves Muscle Mass
Semaglutide Works for Severe Obesity in Youth: Study
Obesity Drugs, Surgery Cut More Fat-Free Mass Than Diet
Oral GLP-1 Drug Aids Weight Loss Maintenance
Injectable Weight Loss Maintained With Oral Orforglipron
Tirzepatide Users 7x More Likely to Maintain Weight Loss
Ancient Medicine Boosts Heart Health, UMCG Finds
Eneboparatide Boosts Calcium in Hypoparathyroidism Trial
Testosterone Boost Aids Men's Recovery Post-Prostate Surgery
Orforglipron Analyzed for Obesity in Seniors 65+
Research Shows Semaglutide Effective for Seniors 65+
Rewiring Smoking Urge
Constipation Drug Found to Shield Kidneys
Lithium May Curb Impulsive Decisions Linked to Suicide
MHRA Approves Dawnzera for Rare Syndrome Treatment
Peptide Injections: Boosting Injury Recovery?
Sylvester Cancer Center's ASCO 2026 Tip Sheet Released
Microbial Extract Going Global
GLP-1 Weight-Loss Drugs: Brain Health Benefits?
One Dose Of Psilocybin Changes Human Brain
Psilocybin Dose Alters Human Brain
New Combo Therapy Boosts Outcomes in Toughest IBD Cases
US Adults Favor Cannabis Microdosing Over Psychedelics
Low-Dose Eye Drops Manage Adult Myopia for 24 Hours
GLP-1 Drugs: From Lab Discovery to Weight-Loss Miracle
New Treatment Lowers Breast Density, Fewer Side Effects
Research Highlights Dangers of Mixing Edibles, Alcohol Driving
MHRA Approves Lynavoy for Biliary Disease Itch
Weekly GLP-1 Boosts CBT in Cutting Heavy Drinking
Low Fatty Acid Levels in Mothers Linked to Child Asthma
GLP-1 Drugs Show Lasting Heart Health Benefits
FDA Panel Recommends Truqap for PTEN-Deficient Prostate Cancer
GLP-1 Cuts Heavy Drinking, Obesity in Alcohol Disorder
Common Knee Surgery May Be Ineffective, Harmful
Research: Common Knee Surgery Often Ineffective, Harmful
Pfizer Inks Three Vyndamax Settlement Deals
Saphnelo Autoinjector Approved for Lupus Self-Use in US
COSMOS Study: 75% of Seniors Use Complementary Therapies
Vitamin D's Role in Diabetes Prevention Tied to Genes
Menopause Supplements: What Evidence Reveals
Triple-pill Lowers Recurrent Stroke Risk By 40%
Triple-Pill Cuts Stroke Recurrence Risk by 40%
Anti-Inflammatory Drug Boosts Heart Recovery Post-Attack
Pfizer Unveils Oncology Advances at ASCO 2026
SGLT2 Inhibitors: New Hope for Cirrhotic Ascites
AACR: New Method Halts Cancer, Reduces Need for Surgery
Placebo Effect Rivals Medicine, Needs Body's Consent